文献速递小儿泌尿与泌尿修复前列腺增生与排尿功能障碍

尿髓鞘碱性蛋白:解读维生素D补充治疗儿童干性膀胱过度活动症的三阶段临床研究

Is urinary myelin basic protein the key to understanding the role of vitamin D supplementation in paediatric overactive bladder-dry? Results from a three-stage clinical investigation.
PubMed 文献 · BJU Int · 2026-03-19

本研究分三阶段验证尿髓鞘碱性蛋白(uMBP)作为25(OH)D<35 ng/mL的儿童干性膀胱过度活动症(OAB-dry)的诊断与预后生物标志物,并探索维生素D补充是否靶向可逆的神经髓鞘化通路。横断面队列(n=216)显示uMBP/Cr与25(OH)D强负相关(ρ=-0.69,P<0.001),诊断AUC为0.80;12周多中心RCT(n=180)中,高剂量VDS+SU在减少排尿频率上优于索利那新+SU(校正差2.7次/天,P<0.001),且基线uMBP/Cr修饰疗效(Ptrend<0.001),uMBP/Cr下降介导35.2%的疗效。

要点

  • uMBP/Cr在25(OH)D<35 ng/mL的OAB-dry患儿中升高,与维生素D水平强负相关(ρ=-0.69)。
  • uMBP/Cr诊断该亚型OAB的AUC为0.80,可作为预测性生物标志物。
  • VDS+SU减少排尿频率优于索利那新+SU(校正差2.7次/天,P<0.001),基线uMBP/Cr越高疗效越好。

核心结论

  • uMBP是识别25(OH)D<35 ng/mL的‘神经易损’儿童OAB-dry亚型的预测性生物标志物。
  • uMBP/Cr下降介导35.2%的VDS疗效,支持髓鞘修复机制。
  • 儿童OAB可能是低维生素D相关神经轴易损性的哨兵征象。

研究设计与样本

  • 三阶段研究:尿蛋白质组学发现候选标志物;横断面队列诊断验证(n=216);12周多中心RCT(n=180)。
  • RCT将25(OH)D<35 ng/mL的OAB-dry患儿按1:1随机至高剂量VDS(2400 IU/天)+SU或索利那新(5 mg/天)+SU。
  • 主要结局为每日排尿频率变化,评估基线uMBP/Cr与治疗反应的交互作用,并行 moderated mediation 分析。

主要发现

  • uMBP/Cr在25(OH)D<35 ng/mL的OAB-dry患儿中显著升高,与25(OH)D强负相关(ρ=-0.69,P<0.001)。
  • uMBP/Cr诊断25(OH)D<35 ng/mL的儿童OAB的AUC为0.80。
  • RCT中VDS+SU较索利那新+SU显著减少排尿频率(校正差2.7次/天,P<0.001)。
  • 基线uMBP/Cr显著修饰疗效:基线越高,VDS+SU症状改善越大(Ptrend<0.001)。
  • 治疗期间uMBP/Cr下降介导35.2%的VDS对排尿频率的疗效。

关键数值与推荐

  • 研究纳入25(OH)D水平<35 ng/mL的OAB-dry患儿。
  • VDS剂量为2400 IU/天,索利那新剂量为5 mg/天,疗程12周。
  • uMBP/Cr诊断AUC为0.80,与25(OH)D相关系数ρ=-0.69(P<0.001)。
  • VDS+SU与索利那新+SU的排尿频率校正差为2.7次/天(P<0.001)。
  • uMBP/Cr下降介导35.2%的VDS疗效。

临床怎么用

  • 对25(OH)D<35 ng/mL的OAB-dry患儿可检测uMBP/Cr以识别‘神经易损’亚型。
  • 基线uMBP/Cr较高的患儿可能从高剂量维生素D补充联合标准 urotherapy 中更多获益。
  • uMBP/Cr动态下降可作为监测VDS治疗反应的潜在指标。

局限性

  • 原文未报告RCT的具体盲法设计及长期随访数据。
  • 原文未报告uMBP/Cr的临床阈值或成本效益信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To validate urinary myelin basic protein (uMBP) as a mechanism-based diagnostic and prognostic biomarker for paediatric overactive bladder-dry (OAB-dry) in children with 25-hydroxyvitamin D (25[OH]D) levels of <35 ng/mL, and to explore whether vitamin D supplementation (VDS) targets a reversible neuromyelination pathway. PATIENTS AND METHODS: This three-phase study comprised: (i) discovery of candidate biomarkers via urinary proteomics; (ii) diagnostic validation in a cross-sectional cohort (n = 216); and (iii) a 12-week multicentre randomised controlled trial (RCT, n = 180). Children with OAB-dry and 25(OH)D level of <35 ng/mL were randomised (1:1) to receive high-dose VDS (2400 IU/day) plus standard urotherapy (SU) or solifenacin (5 mg/day) plus SU. The primary outcome was the change in daily voiding frequency. We evaluated the interaction between baseline uMBP/creatinine ratio (uMBP/Cr) and treatment response and performed moderated mediation analysis to assess the mechanistic role of uMBP/Cr reduction. RESULTS: The uMBP/Cr was significantly elevated in paediatric OAB-dry with vitamin D levels of <35 ng/mL and showed a strong negative correlation with 25(OH)D levels (ρ = -0.69, P < 0.001). It achieved an area under the curve of 0.80 for diagnosing paediatric OAB with 25(OH)D levels of <35 ng/mL. In the RCT, VDS + SU demonstrated superior efficacy compared to solifenacin + SU in reducing voiding frequency (adjusted difference: 2.7 voids/day, P < 0.001). Importantly, baseline uMBP/Cr significantly modified the treatment effect: higher baseline levels predicted a greater reduction in symptoms with VDS + SU (Ptrend < 0.001). Furthermore, the reduction in uMBP/Cr during treatment mediated 35.2% of the therapeutic benefit of VDS on voiding frequency, supporting a treatment mechanism involving myelin restoration. CONCLUSION: Urinary MBP serves as a predictive biomarker for a distinct 'neuro-vulnerable' paediatric OAB-dry subtype, characterised by 25(OH)D levels of <35 ng/mL. These findings position uMBP as a potential tool for precision treatment stratification and suggest that paediatric OAB may represent a sentinel sign of underlying neural axis vulnerability associated with low vitamin D status.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Chen H, Zhang Z, Ye Z, et al. Is urinary myelin basic protein the key to understanding the role of vitamin D supplementation in paediatric overactive bladder-dry? Results from a three-stage clinical investigation. BJU Int. 2026. PMID: 41854167. doi:10.1111/bju.70228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。